Ìý | Module | ITN coverage | IRS coverage | Malaria case management |
---|---|---|---|---|
DRC | Spectrum-Malaria | Usage: 55% | 0.27% | 6.6% |
LiST | ITN owning and/or IRS-sprayed: 70% | 1.7% | ||
Zambia | Spectrum-Malaria | Usage: 68.8% | 35.6% | 44.1% |
LiST | ITN owning and/or IRS-sprayed: 74.7% | 18.4% | ||
Coverage-standardized, DRC & Zambiab | Spectrum-Malaria | • 51% ITN usage at 2014 & 2015; • 70% ITN usage as target for 2016–2020; • IRS: 0.28% throughout 2014–2030. | • 10% at 2014 & 2015; • 40% as target for 2016–2020 | |
LiST | • 77% ITN owning and/or IRS sprayed at 2014 & 2015; • 98% as target for 2016–2020 | • 10% at 2014 & 2015; • 40% as target for 2016–2020. | ||
Data source & definition | Spectrum-Malaria | WHO/MAPÌý2015 [24], % of national population sleeping under an ITN (including areas with PfPRÌý=Ìý0). | WHO 2015 [1], % of national population protected (all ages, including areas with PfPRÌý=Ìý0) | ACT treatment of RDT-positive (and RDT-negative) fevers in children 0–4Ìýyears [28], applied to uncomplicated malaria cases in all age groups |
LiST | Households owning ≥1 ITNs or protected by IRS as measured in the most recent national-representative household survey (usually MIS, MICS or DHS)a | Children 0–4Ìýyears with a fever treated within 48Ìýh of fever onset with an artemisinin-containing compound i.e. ACT as measured in the most recent national-representative household survey (usually MIS, MICS or DHS)a |